Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329) [Phase 3]
Phase 3 trial of MK-217A-alendronate sodium 70-mg/Vitamin D3 5600 IU combination tablet in osteoporosis has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis [Phase 3]
A Phase 3 clinical trial evaluating denosumab for postmenopausal osteoporosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Denosumab Adherence Preference Satisfaction Study [Phase 3]
Phase 3 trial assessing adherence, preference, and satisfaction with denosumab in osteoporosis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
This citation notes the completion of a study evaluating physical and metabolic abnormalities in HIV-infected and uninfected children and yo…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer [Phase 3]
Phase 3 trial evaluating zoledronate to prevent chemotherapy-induced bone loss in premenopausal women after breast cancer surgery; the study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab [Phase 3]
A Phase 3 trial in Indian postmenopausal women with osteoporosis completed and posted results evaluating the efficacy and safety of denosuma…
-
FDA approval · 2013-12-23FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Fosamax (alendronate sodium) submitted by Organon LLC.
-
FDA approval · 2013-12-23FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)
The FDA approved a supplemental application for BINOSTO (alendronate sodium) from Radius Health, Inc., resulting in changes to the product l…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Improving Osteoporosis Care in a Home Health Setting [NA]
A University of Alabama at Birmingham–sponsored trial aimed at improving osteoporosis care in a home health setting has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis [Phase 3]
Phase 3 study evaluating Bazedoxifene/Conjugated Estrogens on endometrial safety and postmenopausal osteoporosis has completed, with results…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women [Phase 3]
Phase 3 study evaluating a bazedoxifene/conjugated estrogens combination in postmenopausal women has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Study Evaluating Changes In Mammographic Breast Density
Pfizer-sponsored clinical trial evaluating changes in mammographic breast density in osteoporosis has completed, with results posted in Dece…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: The Effect of Exercise Training in the Community-dwelling Adults With Chronic Disorders [NA]
A clinical trial assessed the effects of exercise training in community-dwelling adults with chronic disorders, including osteoporosis and o…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Patient- and Physician-Based Osteoporosis Education [Phase 1]
Phase 1 trial update evaluating patient- and physician-based education for osteoporosis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Long-term Investigation of Resveratrol in Obesity [NA]
A long-term clinical trial evaluating resveratrol in obesity and related metabolic and inflammatory conditions has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Alendronate and/or Parathyroid Hormone for Osteoporosis [Phase 2]
Phase 2 clinical trial evaluating alendronate and/or parathyroid hormone for osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Effects of Parathyroid Hormone in Men With Osteoporosis [Phase 3]
Phase 3 trial evaluating the effects of parathyroid hormone in men with osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Zoledronic Acid in MS-patients With Osteoporosis [Phase 3]
A Phase 3 trial of zoledronic acid in multiple sclerosis patients with osteoporosis was terminated; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: A Study of Changes in Bone Mineral Density as a Function of Consuming Two Different Forms of Calcium Carbonate [NA]
A clinical trial update examining changes in bone mineral density when consuming two different forms of calcium carbonate in individuals wit…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women [Phase 3]
Phase 3 trial comparing oral calcitonin to nasal spray calcitonin in postmenopausal osteoporosis completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy [Phase 3]
A Phase 3 trial evaluating toremifene citrate to prevent bone fractures in men with prostate cancer on androgen deprivation therapy has comp…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Evaluation of Exercise Benefits to Promote Health Aging Among Chronically Ill Geriatrics in a Community [NA]
A completed clinical trial evaluating the benefits of exercise to promote healthy aging among chronically ill elderly in a community setting…
-
FDA approval · 2013-11-07FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for FOSAMAX PLUS D (alendronate sodium and cholecalciferol) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: PTH & Ibandronate Combination Study (PICS) [Phase 2, Phase 3]
Clinical trial update for a PTH and ibandronate combination (PICS) in osteoporosis reports completion of Phase 2/Phase 3 with results posted…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density [Phase 3]
Phase 3 randomized, open-label trial comparing immunogenicity and safety of denosumab delivered via pre-filled syringe versus vial in adults…